Medication info
Miofenil SR Extended-Release Tablets (Eperisone Hydrochloride)

Miofenil SR Extended-Release Tablets (Eperisone Hydrochloride)

Prescription medicationTablet경구
Ingredient · strength
Eperisone Hydrochloride›75mg / 1 tablet
Manufacturer / importer
구주제약(주)
Appearance
White to almost white round extended-release film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201905617 · Approved 2019.08.08 · Insurance code 669805510

Summary

Main use
Relief of muscular spasms associated with musculoskeletal disorders (cervical spondylosis, periarthritis of the shoulder)
Who takes it
Adults
Adult dose
This medication is an extended-release tablet, which should be taken whole without crushing, splitting, or chewing. Adults should take 1 tablet (75 mg of eperisone hydrochloride) orally after meals, twice a day. Dosage may be adjusted according to age and symptoms.

Ingredients

Manufacturer
구주제약(주)

Efficacy & effects

Relief of muscular spasms associated with musculoskeletal disorders (cervical spondylosis, periarthritis of the shoulder)

  • Muscular spasms
  • cervical spondylosis
  • periarthritis of the shoulder
  • lower back pain
View approved original text

This medication is used to relieve muscular spasms associated with musculoskeletal disorders such as cervical spondylosis, periarthritis of the shoulder, and lower back pain.

How to take

Adult dose

This medication is an extended-release tablet, which should be taken whole without crushing, splitting, or chewing. Adults should take 1 tablet (75 mg of eperisone hydrochloride) orally after meals, twice a day. Dosage may be adjusted according to age and symptoms.

Precautions

This medication should not be used in patients with hypersensitivity to this drug or in patients with severe myasthenia gravis. Patients with a history of hypersensitivity to the drug or liver function issues should use this medication with caution as liver function may worsen. While taking this medication, rare allergic reactions or severe skin conditions may occur; therefore, if symptoms such as redness, itching, urticaria, swelling, shortness of breath, fever, blisters, or conjunctival injection appear, the medication should be discontinued immediately and medical attention should be sought. Various side effects, including abnormal liver or kidney function, blood abnormalities, neurological symptoms, gastrointestinal issues, and urinary symptoms, may occur, so the patient's condition should be monitored closely. In clinical studies and post-marketing surveillance, side effects such as dizziness, headache, drowsiness, dyspepsia, diarrhea, and localized edema have been reported, and it is advisable to consult a healthcare professional if these symptoms occur. Feeling weak, unsteady, or drowsy may occur while taking this medication, so it is advisable to avoid driving or operating dangerous machinery. If used in combination with other muscle relaxants, there may be an interaction that causes vision impairment, so caution is needed when co-administering. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and nursing mothers should avoid use if possible or discontinue breastfeeding. Safety in children has not been fully established, so it should be used with caution in pediatric patients. Elderly patients may have decreased physical function, so special caution such as adjusting the dosage is required.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (edema), tightness in the chest, difficulty breathing, shock and anaphylactic reactions, toxic epidermal necrolysis (Lyell's syndrome), mucocutaneous syndrome (Stevens-Johnson syndrome), severe rashes, blisters, skin peeling, pain in mouth/eye mucosa, anaphylaxis, angioedema

Mild side effects

  • Nausea
  • vomiting
  • loss of appetite
  • discomfort in the stomach
  • thirst
  • constipation
  • diarrhea
  • abdominal pain
  • bloating
  • stomatitis
Show 27 more
  • insomnia
  • drowsiness
  • headache
  • limb paralysis
  • stiffness of the body
  • limb tremor
  • proteinuria
  • increased BUN
  • anemia
  • rash
  • itching
  • polymorphous exudative erythema
  • weakness
  • unsteadiness
  • general malaise
  • dizziness
  • decreased muscle tone
  • facial flushing
  • sweating
  • swelling
  • palpitations
  • hiccups
  • dyspepsia
  • abnormal sensations
  • decreased sensation
  • exacerbation of headache
  • etc.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C. Avoiding excessively hot or cold places is important to maintain the drug's effectiveness.

Appearance and packaging

Appearance

White to almost white round extended-release film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.